128 related articles for article (PubMed ID: 8841582)
1. Synthesis of alpha-anomeric homopyrimidine oligo DNA phosphorothioates and their physicochemical and biochemical properties.
Shinozuka K; Yamada N; Sawai H
Nucleic Acids Symp Ser; 1995; (34):121-2. PubMed ID: 8841582
[TBL] [Abstract][Full Text] [Related]
2. Abasic oligodeoxyribonucleoside phosphorothioates: synthesis and evaluation as anti-HIV-1 agents.
Iyer RP; Uznanski B; Boal J; Storm C; Egan W; Matsukura M; Broder S; Zon G; Wilk A; Koziolkiewicz M
Nucleic Acids Res; 1990 May; 18(10):2855-9. PubMed ID: 2349087
[TBL] [Abstract][Full Text] [Related]
3. Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology.
Gao WY; Han FS; Storm C; Egan W; Cheng YC
Mol Pharmacol; 1992 Feb; 41(2):223-9. PubMed ID: 1371582
[TBL] [Abstract][Full Text] [Related]
4. Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus.
Matsukura M; Shinozuka K; Zon G; Mitsuya H; Reitz M; Cohen JS; Broder S
Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7706-10. PubMed ID: 3499613
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of phosphorothioate analogues of oligodeoxyribonucleotides and their antiviral activity against human immunodeficiency virus (HIV).
Matsukura M; Zon G; Shinozuka K; Stein CA; Mitsuya H; Cohen JS; Broder S
Gene; 1988 Dec; 72(1-2):343-7. PubMed ID: 3243433
[TBL] [Abstract][Full Text] [Related]
6. Effect of structural variations in cholesteryl-conjugated oligonucleotides on inhibitory activity toward HIV-1.
Farooqui F; Sarin PS; Sun D; Letsinger RL
Bioconjug Chem; 1991; 2(6):422-6. PubMed ID: 1805939
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and nuclease susceptibility of alpha-oligodeoxyribonucleotide phosphorothioate.
Shinozuka K; Morita T; Sawai H
Nucleic Acids Symp Ser; 1991; (25):101-2. PubMed ID: 1842039
[TBL] [Abstract][Full Text] [Related]
8. Solid-phase synthesis of stereoregulated oligodeoxyribonucleoside phosphorothioates.
Oka N; Yamamoto M; Sato T; Wada T
Nucleic Acids Symp Ser (Oxf); 2006; (50):123-4. PubMed ID: 17150848
[TBL] [Abstract][Full Text] [Related]
9. Novel method of synthesis of oligo(deoxyribonucleoside phosphorothioates).
Stec WJ
Nucleic Acids Symp Ser; 1991; (25):171-2. PubMed ID: 1842071
[TBL] [Abstract][Full Text] [Related]
10. 2',5'-linked oligo-3'-deoxyribonucleoside phosphorothioate chimeras: thermal stability and antisense inhibition of gene expression.
Bhan P; Bhan A; Hong M; Hartwell JG; Saunders JM; Hoke GD
Nucleic Acids Res; 1997 Aug; 25(16):3310-7. PubMed ID: 9241246
[TBL] [Abstract][Full Text] [Related]
11. Physicochemical properties of phosphorothioate oligodeoxynucleotides.
Stein CA; Subasinghe C; Shinozuka K; Cohen JS
Nucleic Acids Res; 1988 Apr; 16(8):3209-21. PubMed ID: 2836790
[TBL] [Abstract][Full Text] [Related]
12. Novel route to oligo(deoxyribonucleoside phosphorothioates). Stereocontrolled synthesis of P-chiral oligo(deoxyribonucleoside phosphorothioates).
Stec WJ; Grajkowski A; Koziolkiewicz M; Uznanski B
Nucleic Acids Res; 1991 Nov; 19(21):5883-8. PubMed ID: 1945876
[TBL] [Abstract][Full Text] [Related]
13. Phosphorothioate and cordycepin analogues of 2',5'-oligoadenylate: inhibition of human immunodeficiency virus type 1 reverse transcriptase and infection in vitro.
Montefiori DC; Sobol RW; Li SW; Reichenbach NL; Suhadolnik RJ; Charubala R; Pfleiderer W; Modliszewski A; Robinson WE; Mitchell WM
Proc Natl Acad Sci U S A; 1989 Sep; 86(18):7191-4. PubMed ID: 2476814
[TBL] [Abstract][Full Text] [Related]
14. Backbone modified oligodeoxynucleotides: stereoselective synthesis of methylphosphonates and HIV inhibitory capacity of phosphorothioates.
Engels JW; Daum T; Frauendorf A; Lüking S; Mag M; Müller WE; Muth J; Rosmanitz P
Nucleic Acids Symp Ser; 1991; (24):83-6. PubMed ID: 1841388
[TBL] [Abstract][Full Text] [Related]
15. [In vitro anti-HIV activity of phosphorothioate alpha-anomeric oligodeoxynucleotides].
Rayner B; Matsukura M; Morvan F; Cohen JS; Imbach JL
C R Acad Sci III; 1989; 310(3):61-4. PubMed ID: 2516764
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and property of alpha-oligodeoxynucleotide phosphorothioate.
Shinozuka K; Hirota Y; Morita T; Sawai H
Nucleic Acids Symp Ser; 1992; (27):119-20. PubMed ID: 1289786
[TBL] [Abstract][Full Text] [Related]
17. Effect of the extent of thiolation and introduction of phosphorothioate internucleotide linkages on the anti-HIV activity of Suligovir [(s4dU)35].
Horváth A; Beck Z; Bardos TJ; Dunn JA; Aradi J
Bioorg Med Chem Lett; 2006 Oct; 16(20):5321-3. PubMed ID: 16920358
[TBL] [Abstract][Full Text] [Related]
18. Analysis of oligo(deoxynucleoside phosphorothioate)s and their diastereomeric composition.
Wilk A; Stec WJ
Nucleic Acids Res; 1995 Feb; 23(3):530-4. PubMed ID: 7885850
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of G-quartet-mediated tetramer formation.
Wyatt JR; Davis PW; Freier SM
Biochemistry; 1996 Jun; 35(24):8002-8. PubMed ID: 8672504
[TBL] [Abstract][Full Text] [Related]
20. Phosphorothioate oligodeoxyribonucleotides inhibit ribonuclease L thereby disabling a mechanism of interferon action.
Player MR; Torrence PF
Bioorg Med Chem Lett; 1999 Mar; 9(6):891-4. PubMed ID: 10206556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
